881 related articles for article (PubMed ID: 32600374)
1. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
[TBL] [Abstract][Full Text] [Related]
2. HEROIC: a 5-year observational cohort study aimed at identifying novel factors that drive diabetic kidney disease: rationale and study protocol.
Mccafferty K; Caplin B; Knight S; Hockings P; Wheeler D; Fan SL; Hulthe J; Kleta R; Ashman N; Papastefanou V; Mehta H; Salama A; Hadzovic S; Chowdhury TA; Jarl L; Unwin R; Challis B; Sundgren AK; Yaqoob MM
BMJ Open; 2020 Sep; 10(9):e033923. PubMed ID: 32912939
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of quantitative contrast-enhanced ultrasound (CEUS) for early detection of renal hyperperfusion in diabetic kidney disease.
Wang L; Wu J; Cheng JF; Liu XY; Ma F; Guo LH; Xu JM; Wu T; Mohan C; Peng A; Xu HX; Song YX
J Nephrol; 2015 Dec; 28(6):669-78. PubMed ID: 25712236
[TBL] [Abstract][Full Text] [Related]
4. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
[TBL] [Abstract][Full Text] [Related]
5. Trajectories of kidney function in diabetes: a clinicopathological update.
Oshima M; Shimizu M; Yamanouchi M; Toyama T; Hara A; Furuichi K; Wada T
Nat Rev Nephrol; 2021 Nov; 17(11):740-750. PubMed ID: 34363037
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers for prognosticating diabetic kidney disease progression.
Swaminathan SM; Rao IR; Shenoy SV; Prabhu AR; Mohan PB; Rangaswamy D; Bhojaraja MV; Nagri SK; Nagaraju SP
Int Urol Nephrol; 2023 Apr; 55(4):913-928. PubMed ID: 36271990
[TBL] [Abstract][Full Text] [Related]
7. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Supersonic Shear Wave Imaging-Derived Renal Parenchyma Stiffness Between Diabetes Mellitus Patients With and Without Diabetic Kidney Disease.
Shi LQ; Sun JW; Miao HH; Zhou XL
Ultrasound Med Biol; 2020 Jul; 46(7):1630-1640. PubMed ID: 32404297
[TBL] [Abstract][Full Text] [Related]
9. A study of the natural history of diabetic kidney disease (DKD).
Altemtam N; Russell J; El Nahas M
Nephrol Dial Transplant; 2012 May; 27(5):1847-54. PubMed ID: 22058177
[TBL] [Abstract][Full Text] [Related]
10. Validation of a protein biomarker test for predicting renal decline in type 2 diabetes: The Fremantle Diabetes Study Phase II.
Peters KE; Davis WA; Ito J; Bringans SD; Lipscombe RJ; Davis TME
J Diabetes Complications; 2019 Dec; 33(12):107406. PubMed ID: 31669066
[TBL] [Abstract][Full Text] [Related]
11. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance, diabetic kidney disease, and all-cause mortality in individuals with type 2 diabetes: a prospective cohort study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Zerbini G; Lamacchia O; Nicolucci A; Pugliese G;
BMC Med; 2021 Mar; 19(1):66. PubMed ID: 33715620
[TBL] [Abstract][Full Text] [Related]
13. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
[TBL] [Abstract][Full Text] [Related]
14. Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease.
Coca SG; Nadkarni GN; Huang Y; Moledina DG; Rao V; Zhang J; Ferket B; Crowley ST; Fried LF; Parikh CR
J Am Soc Nephrol; 2017 Sep; 28(9):2786-2793. PubMed ID: 28476763
[TBL] [Abstract][Full Text] [Related]
15. Intra-individual variability of eGFR trajectories in early diabetic kidney disease and lack of performance of prognostic biomarkers.
Kerschbaum J; Rudnicki M; Dzien A; Dzien-Bischinger C; Winner H; Heerspink HL; Rosivall L; Wiecek A; Mark PB; Eder S; Denicolò S; Mayer G
Sci Rep; 2020 Nov; 10(1):19743. PubMed ID: 33184434
[TBL] [Abstract][Full Text] [Related]
16. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
Yamamoto CM; Murakami T; Oakes ML; Mitsuhashi M; Kelly C; Henry RR; Sharma K
Am J Nephrol; 2018; 47(5):283-291. PubMed ID: 29779026
[TBL] [Abstract][Full Text] [Related]
17. Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.
Penno G; Solini A; Orsi E; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Lamacchia O; Scardapane M; Nicolucci A; Pugliese G;
Diabetologia; 2018 Nov; 61(11):2277-2289. PubMed ID: 30032426
[TBL] [Abstract][Full Text] [Related]
18. Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
Pugliese G; Penno G; Natali A; Barutta F; Di Paolo S; Reboldi G; Gesualdo L; De Nicola L;
J Nephrol; 2020 Feb; 33(1):9-35. PubMed ID: 31576500
[TBL] [Abstract][Full Text] [Related]
19. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
[TBL] [Abstract][Full Text] [Related]
20. Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
Cid Ruzafa J; Paczkowski R; Boye KS; Di Tanna GL; Sheetz MJ; Donaldson R; Breyer MD; Neasham D; Voelker JR
Int J Clin Pract; 2015 Aug; 69(8):871-82. PubMed ID: 26011029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
